Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Osteoprosis poses a serious health risk for women. According to Natural News, women have a higher risk of dying from the bone condition than from breast cancer. But the treatment may be just as dangerous.

Fosamax is in a class of drugs called bisphosphonates (also called diphosphonates) that inhibit osteoclast action and the resorption of bone. It is one of the more popular choices for the treatment of osteoporosis. Natural News warns that Fosamax has been shown to increase the risk of ulcers, especially if taken with anti-inflammatory drugs. The publication also questions whether the medication actually strengthens the bone or makes it weaker.

Read the rest of this entry »

The Los Angeles Times on Sunday examined how the business “strategy that has made the pharmaceutical industry one of the wealthiest and most powerful on Earth” might have begun to “betray it.”

Read the rest of this entry »